Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

Alkermes Plc (NASDAQ: ALKS) earnings per share growth forecast for the next five years is 35.00 percent. Alkermes' trailing-twelve-month gross margin is 74.70 percent.

Flamel Technologies S.A. (ADR) (NASDAQ: FLML) EPS growth forecast for the next five years is 33.00 percent. Flamel Technologies' trailing-twelve-month revenue is $42.90 million.

Delcath Systems, Inc. (NASDAQ: DCTH) EPS growth forecast for the next five years is 15.00 percent. Delcath Systems' trailing-twelve-month revenue is $1.40 million.

Petmed Express Inc (NASDAQ: PETS) earnings per share growth forecast for the next five years is 5.00 percent. Petmed Express' PEG ratio is 3.52.